227 related articles for article (PubMed ID: 9422555)
41. Clinical and dosimetric characteristics of temporal lobe injury following intensity modulated radiotherapy of nasopharyngeal carcinoma.
Su SF; Huang Y; Xiao WW; Huang SM; Han F; Xie CM; Lu TX
Radiother Oncol; 2012 Sep; 104(3):312-6. PubMed ID: 22857858
[TBL] [Abstract][Full Text] [Related]
42. Results of excision of cerebral radionecrosis: experience in patients treated with radiation therapy for nasopharyngeal carcinoma.
Wong ST; Loo KT; Yam KY; Hung WM; Fok KF; Yuen SC; Fong D
J Neurosurg; 2010 Aug; 113(2):293-300. PubMed ID: 20151776
[TBL] [Abstract][Full Text] [Related]
43. 1H-MR spectroscopy and diffusion tensor imaging of normal-appearing temporal white matter in patients with nasopharyngeal carcinoma after irradiation: initial experience.
Xiong WF; Qiu SJ; Wang HZ; Lv XF
J Magn Reson Imaging; 2013 Jan; 37(1):101-8. PubMed ID: 22972703
[TBL] [Abstract][Full Text] [Related]
44. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003.
Fu KK; Pajak TF; Trotti A; Jones CU; Spencer SA; Phillips TL; Garden AS; Ridge JA; Cooper JS; Ang KK
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):7-16. PubMed ID: 10924966
[TBL] [Abstract][Full Text] [Related]
45. Cognitive function of patients with nasopharyngeal carcinoma with and without temporal lobe radionecrosis.
Cheung M; Chan AS; Law SC; Chan JH; Tse VK
Arch Neurol; 2000 Sep; 57(9):1347-52. PubMed ID: 10987903
[TBL] [Abstract][Full Text] [Related]
46. Combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer: analysis of dose and fractionation schedule.
Toita T; Kakinohana Y; Ogawa K; Adachi G; Moromizato H; Nagai Y; Maehama T; Sakumoto K; Kanazawa K; Murayama S
Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1344-53. PubMed ID: 12873679
[TBL] [Abstract][Full Text] [Related]
47. Comparison of radiological and clinical features of temporal lobe necrosis in nasopharyngeal carcinoma patients treated with 2D radiotherapy or intensity-modulated radiotherapy.
Mao YP; Zhou GQ; Liu LZ; Guo R; Sun Y; Li L; Lin AH; Zeng MS; Kang TB; Jia WH; Shao JY; Mai HQ; Ma J
Br J Cancer; 2014 May; 110(11):2633-9. PubMed ID: 24809780
[TBL] [Abstract][Full Text] [Related]
48. LASSO-based NTCP model for radiation-induced temporal lobe injury developing after intensity-modulated radiotherapy of nasopharyngeal carcinoma.
Kong C; Zhu XZ; Lee TF; Feng PB; Xu JH; Qian PD; Zhang LF; He X; Huang SF; Zhang YQ
Sci Rep; 2016 May; 6():26378. PubMed ID: 27210263
[TBL] [Abstract][Full Text] [Related]
49. Temporal lobe necrosis: a dwindling entity in a patient with nasopharyngeal cancer after radiation therapy.
Dassarath M; Yin Z; Chen J; Liu H; Yang K; Wu G
Head Neck Oncol; 2011 Feb; 3():8. PubMed ID: 21310054
[TBL] [Abstract][Full Text] [Related]
50. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
51. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.
Butler EB; Teh BS; Grant WH; Uhl BM; Kuppersmith RB; Chiu JK; Donovan DT; Woo SY
Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):21-32. PubMed ID: 10477002
[TBL] [Abstract][Full Text] [Related]
52. Late normal tissue sequelae from radiation therapy for carcinoma of the tonsil: patterns of fractionation study of radiobiology.
Withers HR; Peters LJ; Taylor JM; Owen JB; Morrison WH; Schultheiss TE; Keane T; O'Sullivan B; van Dyk J; Gupta N
Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):563-8. PubMed ID: 7558944
[TBL] [Abstract][Full Text] [Related]
53. Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy.
Ruben JD; Dally M; Bailey M; Smith R; McLean CA; Fedele P
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):499-508. PubMed ID: 16517093
[TBL] [Abstract][Full Text] [Related]
54. Dynamic susceptibility contrast-enhanced perfusion MR imaging in late radiation-induced injury of the brain.
Chan YL; Yeung DK; Leung SF; Lee SF; Ching AS
Acta Neurochir Suppl; 2005; 95():173-5. PubMed ID: 16463845
[TBL] [Abstract][Full Text] [Related]
55. Temporal lobe (TL) damage following surgery and high-dose photon and proton irradiation in 96 patients affected by chordomas and chondrosarcomas of the base of the skull.
Santoni R; Liebsch N; Finkelstein DM; Hug E; Hanssens P; Goitein M; Smith AR; O'Farrell D; Efird JT; Fullerton B; Munzenrider JE
Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):59-68. PubMed ID: 9588918
[TBL] [Abstract][Full Text] [Related]
56. Late course accelerated hyperfractionated radiotherapy of nasopharyngeal carcinoma (LCAF).
He XY; Liu TF; He SQ; Huan SL; Pan ZQ
Radiother Oncol; 2007 Oct; 85(1):29-35. PubMed ID: 17889386
[TBL] [Abstract][Full Text] [Related]
57. Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma.
Le QT; Tate D; Koong A; Gibbs IC; Chang SD; Adler JR; Pinto HA; Terris DJ; Fee WE; Goffinet DR
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1046-54. PubMed ID: 12829140
[TBL] [Abstract][Full Text] [Related]
58. Retrospective analysis of nasopharyngeal carcinoma treated during 1976-1985: late complications following megavoltage irradiation.
Lee AW; Law SC; Ng SH; Chan DK; Poon YF; Foo W; Tung SY; Cheung FK; Ho JH
Br J Radiol; 1992 Oct; 65(778):918-28. PubMed ID: 1422667
[TBL] [Abstract][Full Text] [Related]
59. Early stage nasopharyngeal carcinoma: radiotherapy dose and time factors in tumor control.
Chang JT; See LC; Liao CT; Chen LH; Leung WM; Chen SW; Chen WC
Jpn J Clin Oncol; 1998 Mar; 28(3):207-13. PubMed ID: 9614445
[TBL] [Abstract][Full Text] [Related]
60. Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma.
Lee SW; Suh CO; Chung EJ; Kim GE
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1338-44. PubMed ID: 11955747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
